Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation.

about

Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation.

Item

http://www.wikidata.org/entity/Q38705079

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Assessment of citalopram and e ...... toxicity and gene modulation.

@en

type

Item

label

Assessment of citalopram and e ...... toxicity and gene modulation.

@en

prefLabel

Assessment of citalopram and e ...... toxicity and gene modulation.

@en

P1476

Assessment of citalopram and e ...... toxicity and gene modulation.

@en

P2093

Guillaume Coll

http://www.w3.org/2001/XMLSchema#string

Laurent Sakka

http://www.w3.org/2001/XMLSchema#string

Maryse Chalus

http://www.w3.org/2001/XMLSchema#string

Nathalie Delétage

http://www.w3.org/2001/XMLSchema#string

Stéphane Gobron

http://www.w3.org/2001/XMLSchema#string

Valérie Sylvain-Vidal

http://www.w3.org/2001/XMLSchema#string

Youssef Aissouni

http://www.w3.org/2001/XMLSchema#string

P2860

Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB

Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma

Knockdown of CDK6 enhances glioma sensitivity to chemotherapy

Neutral red uptake assay for the estimation of cell viability/cytotoxicity

Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.

Expression profiling of favorable and unfavorable neuroblastomas.

Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study.

The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.

Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP).

Myb controls G(2)/M progression by inducing cyclin B expression in the Drosophila eye imaginal disc.

P304

42789-42807

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17050

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28467792

http://www.w3.org/2001/XMLSchema#string

P932

5522106

http://www.w3.org/2001/XMLSchema#string